ArticleCureus2025
A Case Report of Rheumatoid Arthritis With a Migratory Pattern.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a systemic autoimmune disease that classically presents with symmetric polyarthritis. However, atypical manifestations such as migratory joint pain can obscure diagnosis, particularly in patients with pre-existing degenerative joint conditions. We report the case of a 74-year-old woman with a history of osteoarthritis (OA), obesity, and multiple comorbidities who developed acute, migratory joint and muscle pain over several weeks. Her symptoms exhibited a shifting pattern, initially involving the left wrist and groin, before progressing to the right upper extremity with notable swelling and functional impairment. Laboratory evaluation revealed a positive anti-cyclic citrullinated peptide (anti-CCP) antibody and elevated inflammatory markers, including C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Rheumatoid factor (RF), antinuclear antibodies (ANA), and antineutrophil cytoplasmic antibodies (cytoplasmic (c-ANCA), perinuclear (p-ANCA), and atypical p-ANCA) were negative. Imaging studies excluded acute structural or vascular pathology. Despite her overlapping OA symptoms and seronegativity for RF, the patient's clinical trajectory and positive anti-CCP supported a diagnosis of RA with an atypical, migratory presentation. She experienced partial symptomatic improvement with corticosteroids and was referred to rheumatology for initiation of disease-modifying antirheumatic drugs (DMARDs). This case underscores the need to consider RA in the differential diagnosis of migratory arthralgia, especially in older adults with existing joint disease, and highlights the diagnostic utility of anti-CCP antibodies in seronegative presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.